Rizvi Rubina Fatima, Schoephoerster Jamee Ann, Desphande Sagar Satish, Usher Michael, Oien Andy Elaine, Peters Maya Marie, Loth Matthew Scott, Bahr Matthew William, Ventz Steffen, Koopmeiners Joseph Stephen, Melton Genevieve B
Division of Computational Health Sciences, Department of Surgery, University of Minnesota, Minneapolis, MN, United States.
Center for Learning Health System Sciences, University of Minnesota, Minneapolis, MN, United States.
JMIR Res Protoc. 2024 Mar 8;13:e52882. doi: 10.2196/52882.
Despite strong and growing interest in ending the ongoing opioid health crisis, there has been limited success in reducing the prevalence of opioid addiction and the number of deaths associated with opioid overdoses. Further, 1 explanation for this is that existing interventions target those who are opiate-dependent but do not prevent opioid-naïve patients from becoming addicted.
Leveraging behavioral economics at the patient level could help patients successfully use, discontinue, and dispose of their opioid medications in an acute pain setting. The primary goal of this project is to evaluate the effect of the 3 versions of the Opioid Management for You (OPY) tool on measures of opioid use relative to the standard of care by leveraging a pragmatic randomized controlled trial (RCT).
A team of researchers from the Center for Learning Health System Sciences (CLHSS) at the University of Minnesota partnered with M Health Fairview to design, build, and test the 3 versions of the OPY tool: social influence, precommitment, and testimonial version. The tool is being built using the Epic Care Companion (Epic Inc) platform and interacts with the patient through their existing MyChart (Epic Systems Corporation) personal health record account, and Epic patient portal, accessed through a phone app or the MyChart website. We have demonstrated feasibility with pilot data of the social influence version of the OPY app by targeting our pilot to a specific cohort of patients undergoing upper-extremity procedures. This study will use a group sequential RCT design to test the impact of this important health system initiative. Patients who meet OPY inclusion criteria will be stratified into low, intermediate, and high risk of opiate use based on their type of surgery.
This study is being funded and supported by the CLHSS Rapid Prospective Evaluation and Digital Technology Innovation Programs, and M Health Fairview. Support and coordination provided by CLHSS include the structure of engagement, survey development, data collection, statistical analysis, and dissemination. The project was initially started in August 2022. The pilot was launched in February 2023 and is still running, with the data last counted in August 2023. The actual RCT is planned to start by early 2024.
Through this RCT, we will test our hypothesis that patient opioid use and diverted prescription opioid availability can both be improved by information delivery applied through a behavioral economics lens via sending nudges directly to the opioid users through their personal health record.
ClinicalTrials.gov NCT06124079; https://clinicaltrials.gov/study/NCT06124079.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/52882.
尽管人们对结束当前的阿片类药物健康危机有着浓厚且不断增长的兴趣,但在降低阿片类药物成瘾率以及与阿片类药物过量相关的死亡人数方面,成效有限。此外,对此的一种解释是,现有的干预措施针对的是阿片类药物依赖者,却未能防止未使用过阿片类药物的患者成瘾。
在患者层面运用行为经济学,有助于患者在急性疼痛情况下成功使用、停用并处理其阿片类药物。本项目的主要目标是通过一项实用随机对照试验(RCT),评估三种版本的“为您管理阿片类药物(OPY)”工具相对于护理标准在阿片类药物使用指标方面的效果。
明尼苏达大学学习健康系统科学中心(CLHSS)的一组研究人员与M Health Fairview合作,设计、构建并测试OPY工具的三个版本:社会影响版、预先承诺版和推荐版。该工具使用Epic Care Companion(Epic公司)平台构建,并通过患者现有的MyChart(Epic系统公司)个人健康记录账户以及通过手机应用程序或MyChart网站访问的Epic患者门户网站与患者互动。我们通过将试点针对接受上肢手术的特定患者群体,用OPY应用程序社会影响版的试点数据证明了其可行性。本研究将采用成组序贯RCT设计来测试这一重要卫生系统举措的影响。符合OPY纳入标准的患者将根据其手术类型分为低、中、高阿片类药物使用风险组。
本研究由CLHSS快速前瞻性评估和数字技术创新项目以及M Health Fairview资助和支持。CLHSS提供的支持和协调包括参与结构、调查开发、数据收集、统计分析和传播。该项目于2022年8月启动。试点于2023年2月启动,目前仍在进行,最后一次数据统计是在2023年8月。实际的RCT计划于2024年初开始。
通过这项RCT,我们将检验我们的假设,即通过行为经济学视角提供信息,直接通过个人健康记录向阿片类药物使用者发送助推信息,可以改善患者的阿片类药物使用情况以及转移处方阿片类药物的可得性。
ClinicalTrials.gov NCT06124079;https://clinicaltrials.gov/study/NCT06124079。
国际注册报告识别码(IRRID):PRR1-10.2196/52882。